Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Best Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex

NCT03958201 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03958201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Best Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Completed
Start date
May 28, 2019
Completion date
March 31, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual paralysis, post anesthesia